Lipichol (Atorvastatin)

Atorvastatin blocks the enzyme HMG‑CoA reductase, a key step in the hepatic synthesis of cholesterol. By inhibiting this pathway, the drug reduces the amount of cholesterol produced by the liver, prompting an increase in LDL‑receptor expression and enhanced clearance of circulating LDL particles, which lowers blood cholesterol concentrations.

The appropriate dose of Lipichol is individualized by the prescribing clinician based on the patient’s baseline lipid profile, cardiovascular risk, age, renal and hepatic function, and any concomitant medications. Dosage adjustments are made to achieve target cholesterol levels while minimizing the risk of adverse effects.

Atorvastatin, the active ingredient in Lipichol, is classified as contraindicated in pregnancy because of potential teratogenic effects. It should not be used by pregnant women, and breastfeeding is generally discouraged unless the benefits outweigh the risks, as the drug may pass into breast milk.

To request Lipichol, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Lipichol (atorvastatin) belongs to the statin class, which is generally more potent and longer‑acting than earlier agents such as simvastatin. Compared with other statins, atorvastatin offers a greater reduction in LDL‑cholesterol at comparable doses and a well‑characterised safety profile, making it a common first‑line choice for lipid management.

Lipichol tablets should be stored at room temperature, below 25 °C, in the original packaging to protect them from moisture and light. Keep the product out of reach of children and avoid storing in areas with high humidity or direct sunlight.

Lipichol is taken orally, usually once daily, with or without food, as directed by the prescriber. The tablet should be swallowed whole with a full glass of water. Patients should follow the dosing schedule provided by their healthcare professional and not alter the regimen without medical advice.

The most serious adverse reactions associated with Lipichol include rhabdomyolysis, which can lead to acute renal failure, and severe liver injury such as hepatitis or liver failure. Patients should be alert for unexplained muscle pain, weakness, dark urine, jaundice, or signs of an allergic reaction and seek immediate medical attention if they occur.

Lipichol is contraindicated in individuals with active liver disease, unexplained persistent elevations of hepatic enzymes, known hypersensitivity to atorvastatin or any excipients, and in pregnant women. Caution is also advised for patients with severe renal impairment, those taking strong CYP3A4 inhibitors, or anyone with a history of statin‑related myopathy.